LONDON (Reuters) - A non-surgical treatment for low-risk prostate cancer in which doctors inject a light-sensitive drug derived from deep-sea bacteria into a patient's bloodstream was shown in a trial ...
HAMILTON, ON, July 31, 2024 /PRNewswire/ - Insight Medbotics, a medical device company combining the accuracy of MRI with the precision of robotics, is pleased to announce two appointments to the ...
A drug activated by laser light successfully destroys early prostate cancer while avoiding side effects that commonly occur with surgery, trial results have shown. The new technique, called ...
The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer screening study in a generation. The £42m trial is being co-led by UCL, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results